GleamWall
中文EN

NASC Can B Corp

Wholesale-Drugs, Proprietaries & Druggists' Sundries · OTC · SEC CIK 1509957 · Fiscal year ends 12/31

Financial factors as of 2023-12-31 (2023Q4), TTM = sum of the last four quarters

Growth

TTM revenue YoY-67.8%
TTM net income YoY34.8%
TTM EPS YoY81.6%
Revenue 3-yr CAGR8.0%
Net income 3-yr CAGR—

Margins

Gross margin16.6%
Operating margin-347.3%
Net margin-451.7%
FCF margin-61.2%
EBITDA margin-282.9%

Returns

ROE-2,317.5%
ROA-75.8%
ROIC (approx.)-1,613.4%
Asset turnover0.17x

Leverage & solvency

Liabilities / assets118.3%
Debt / equity—
Current ratio0.45x
Interest coverage-2.98x

Cash quality & payout

Operating cash flow / net income0.13x
Accruals ratio-65.7%
Payout ratio—
Capex / revenue0.7%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2024Q32024-09-302024Q22024-06-302024Q12024-03-312023Q4*2023-12-312023Q32023-09-302023Q22023-06-302023Q12023-03-312022Q4*2022-12-31
Income statement
Revenue$15,269$272,287$369,096$376,889$418,957$420,593$939,305$666,073
Cost of revenue$415,816$665,471$1.19M-$897,602$1.24M$934,425$524,577$820,817
Gross profit-$400,547-$393,184-$824,065$1.27M-$816,690-$513,832$414,728-$154,744
SG&A expense$2.43M$1.17M$1.69M—$2.76M$1.31M$1.85M—
Operating income-$2.83M-$1.57M-$5.65M-$651,715-$3.58M-$1.82M-$1.43M-$2.59M
Interest expense$430,173$463,366$506,182$1.18M$585,417$416,415$333,967$242,736
Pretax income-$3.26M-$2.03M-$6.16M-$1.81M-$4.17M-$2.03M-$1.73M-$2.90M
Income tax———$0$0$0$9,596—
Net income-$3.26M-$2.03M-$6.16M-$1.81M-$4.17M-$2.03M-$1.74M-$2.90M
EBITDA-$2.83M-$1.54M-$5.34M-$304,681-$3.23M-$1.48M-$1.09M-$2.24M
EPS (basic)-0.05-0.04-0.16—-0.36-0.37-0.36—
EPS (diluted)-0.05-0.04-0.16—-0.36-0.37-0.36—
Weighted avg. shares (diluted)65.44M54.63M37.35M—11.59M5.55M4.90M—
Balance sheet
Cash & equivalents$7,879—$26,582$34,006$31,318$123,445$196,248$73,194
Receivables$1.42M$3.40M$3.60M$3.72M$6.61M$6.72M$6.89M$6.59M
Inventory$155,917$563,370$593,375$1.62M$959,706$1.55M$2.03M$2.02M
Current assets$1.59M$3.98M$4.23M$5.38M$7.63M$8.43M$9.15M$8.70M
PP&E, net—$619,907$649,079$4.11M$4.45M$4.80M$5.10M$5.43M
Intangibles——$3,416$95,144$98,144$101,144$104,144$107,144
Total assets$1.86M$4.92M$5.32M$10.13M$13.08M$14.58M$15.58M$15.56M
Current liabilities$11.64M$11.11M$10.39M$11.98M$12.86M$13.72M$12.85M$12.42M
Total liabilities$11.64M$11.11M$10.39M$11.98M$12.86M$14.03M$13.12M$12.86M
Shareholders' equity-$9.79M-$6.75M-$5.31M-$1.86M$219,602$554,887$2.45M$2.70M
Shares outstanding70.12M61.87M44.80M32.75M26.25M5.70M5.38M2.83M
Cash flow statement
Operating cash flow$9,098-$131,067$216,850$151,438-$206,627-$343,173-$906,133-$526,470
Capital expenditure———$0$0$0$15,000—
Free cash flow———$151,438-$206,627-$343,173-$921,133—
Investing cash flow-$6,470——$369$0$0-$85,000—
Financing cash flow$5,251$108,208-$224,274-$149,119$114,500$270,370$1.11M$565,193
Depreciation & amortization$0$29,172$314,435$347,034$348,224$345,804$346,887$346,512
Stock-based compensation$0$0$1.16M$0$1.45M$0$0$0

Free plan shows the latest 8 periods; Pro shows all 38 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.